Insights

Analysis and perspective on the competitive landscape.

How to read a ClinicalTrials.gov record

Most reporting about trials is downstream of one public database. Reading it yourself is more useful than any summary, including ours. The fields that carry the most meaning NCT number. The unique identifier. Quote it and anyone can find exactly the study you mean. Status. Recruiting, active but not recruiting, completed, terminated, withdrawn. Terminated means […]

Read more →

Heart failure, AFib and hypertension: current trial activity

Three long-standing cardiovascular conditions, and how much new study activity each is attracting. Studies with a start date since 1 July 2026: Hypertension: 335 Heart failure: 235 Atrial fibrillation: 128 Cholesterol and lipids: 42 The lipid figure is the one that tends to surprise people. Cholesterol management affects an enormous number of patients, yet it […]

Read more →

What the registry says about new cardiovascular trials this quarter

Since 1 July 2026, ClinicalTrials.gov has recorded 1,645 studies under cardiovascular disease with a start date in that window. 1,249 are interventional and 415 are currently recruiting. By phase Phase 1: 98 Phase 2: 168 Phase 3: 121 Phase 4: 86 The phase spread here is noticeably flatter than in cancer, where Phase 2 studies […]

Read more →

Who is running cardiometabolic trials

Among studies registered with a start date since 1 July 2026, the most frequent lead sponsors in cardiovascular disease are: Assiut University — 32 studies Mayo Clinic — 11 studies Silvia Ulrich Somaini — 8 studies University of Texas Southwestern Medical Center — 7 studies Assistance Publique – Hôpitaux de Paris — 7 studies University […]

Read more →

Obesity now outnumbers every other cardiometabolic trial category

Among cardiovascular and metabolic studies registered with a start date since 1 July 2026, obesity is the single largest category — and not narrowly: Obesity: 478 Hypertension: 335 Type 2 diabetes: 287 Heart failure: 235 Atrial fibrillation: 128 Cholesterol / lipids: 42 Obesity at 478 studies runs ahead of hypertension (335) and roughly double heart […]

Read more →